Zhejiang Wecome Pharmaceutical Company Limited’s Net Profit Dropped 25.1% in First Three Quarters of 2023

Zhejiang Wecome Pharmaceutical Company Limited (浙江维康药业股份有限公司) (300878.SZ) reported a net profit of 70.9 million yuan in the first three quarters of 2023, down 25.1% year-on-year.

Meanwhile, the company posted 432 million yuan in revenue, down 8.9% year-on-year.

At the end of the reporting period, it had 2.1 billion yuan in total assets and 599.8 million yuan in total liabilities, with a liability-to-asset ratio of 28.8%.